首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Application of liquid chromatography–tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneally
【24h】

Application of liquid chromatography–tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneally

机译:液相色谱-串联质谱法测定腹膜内阿片类药物治疗大鼠脑透析液中的阿片类药物

获取原文
获取原文并翻译 | 示例
           

摘要

We have determined three opioidmimetics (compounds I–III) in the rat brain dialysates after intraperitoneal (i.p.) administration of compounds I–III using a liquid chromatography/mass spectrometry with tandem mass spectrometry (LC–MS/MS). The dialysate samples with methanol were directly analyzed by online column-switching liquid chromatography. Using multiple reaction monitoring (MRM, product ions m/z 421 of m/z 657 for compound I, m/z 421 of m/z 643 for compound II, and m/z 407 of m/z 629 for compound III) on LC–MS/MS with electrospray ionization (ESI), opioidmimetics in rat brain dialysates were determined. Calibration curves of the method showed a good linearity in the range of 10–100 ng/ml for each compound. The limit of determination was estimated to be ca. 1 ng/ml for compounds II and III, and ca. 5 ng/ml for compound I, respectively. The precision of analysis showed coefficients of variation ranging from 4.7 to 10.4% at compound III concentration (10–100 ng/ml) in Ringer's solution. As a result, the procedure proved to be very suitable for routine analysis. The method was applied to the analysis of three opioidmimetics in the brain dialysate samples from rats treated with these compounds.
机译:使用液相色谱/质谱联用质谱(LC-MS / MS),腹膜内(i.p.)施用化合物I-III后,我们在大鼠脑透析液中确定了三种阿片样物质(化合物I-III)。通过在线柱切换液相色谱法直接分析含甲醇的透析液样品。使用多重反应监测(MRM,化合物I的m / z 657的产物离子m / z 421,化合物II的m / z 643的m / z 421和化合物III的m / z 629的m / z 407)使用电喷雾电离(ESI)的LC–MS / MS和大鼠脑透析液中的阿片类药物被测定。该方法的校准曲线显示每种化合物在10–100 ng / ml的范围内具有良好的线性。确定的极限估计为约。化合物II和III约为1 ng / ml,对于化合物I分别为5ng / ml。分析的精确度表明,在林格氏溶液中,化合物III浓度(10–100 ng / ml)时,变异系数范围为4.7%至10.4%。结果,该程序非常适合常规分析。该方法用于分析用这些化合物治疗的大鼠的脑透析液样品中的三种阿片样物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号